The differences became even more prominent when comparing patients with high expression levels of MUC5B—5 patients from the control group (or 35.7%) displayed increased MUC5B expression versus 40 patients (or 60.6%) in the CRS group. The gene discussed is MUC5B; the disease is congenital rubella syndrome.